| Primary information |
|---|
| ID | antitb_1768, |
| Name | US 2012/0197004 |
| N-Terminal modification | FKAB-1Gz |
| C-Terminal Modification | GF-Tic-Oic-G-Dab-Tic-Oic-GF-Tic-Oic-G-Dab-Tic-Dab-Dab-Dab-Dab |
| Chemical Modification | Acetylation |
| Linear/Cyclic | Amidation |
| Length | Tic = tetrahydroisoquinolinecarboxylic acid, Oic = Octahydroindolecarboxylic acid, Dab = 2,4-diaminobutanoic acid |
| Chirality | Linear |
| Nature | 19 |
| Source | L |
| Origin | Hydrophobic |
| Species | Synthetic |
| Inhibition Concentration | Mycobacterium ranae |
| In Vitro/ In vivo | Mycobacterium ranae |
| Cell Line | MIC = 10 μM |
| Inhibition Concentration | Both |
| Sequence | 2012 |
| Cytotoxicity | None |
| In vivo Model | NA |
| Lethal Dose | not tested |
| Immune Responce | Mice |
| Mechanism of Action | NA |
| Target | NA |
| Combination Therapy | NA |
| Other activities | NA |
| PMID | None |
| Year of Publication | Anti-bacterial (Salmonella typhimurium, Staphylococcus aureus, Bacillus subtillis) |
Tertiary Structure
(Technique) | Not Predicted), |